EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited.
Kamin, Wolfgang
EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited. [electronic resource] - Current medical research and opinion 03 2018 - 475-485 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1473-4877
10.1080/03007995.2017.1402754 doi
Acute Disease
Bronchitis--drug therapy
Child, Preschool
Humans
Pharyngitis--drug therapy
Phytotherapy
Plant Extracts--therapeutic use
Randomized Controlled Trials as Topic
Respiratory Tract Infections--drug therapy
Sinusitis--drug therapy
Treatment Outcome
EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited. [electronic resource] - Current medical research and opinion 03 2018 - 475-485 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1473-4877
10.1080/03007995.2017.1402754 doi
Acute Disease
Bronchitis--drug therapy
Child, Preschool
Humans
Pharyngitis--drug therapy
Phytotherapy
Plant Extracts--therapeutic use
Randomized Controlled Trials as Topic
Respiratory Tract Infections--drug therapy
Sinusitis--drug therapy
Treatment Outcome